/
Respiratory
163Diseases↗
824Pipeline Programs↗
1.2KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
5,172
clinical trials
Completed3,006 · 58%
Recruiting668 · 13%
Unknown status404 · 8%
Terminated372 · 7%
Not yet recruiting298 · 6%
Active, not recruiting183 · 4%
Other241 · 5%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
26programs
21programs
17programs
16programs
15programs
Landscape
Diseases
LAM
Most programs12
Programs
1,240
Trials
5
Recruiting
Pre
4
P1
1
P2
6
P3
1
Appr
1
Most programs:
Amgen
AmgenAsthma
Most trials136
Programs
278
Trials
111
Recruiting
Pre
71
P1
3
P2
23
P3
19
Appr
46
Most programs:
GSK
GSKChronic Obstructive Pulmonary Disease
Highest activity73
Programs
253
Trials
38
Recruiting
Pre
49
P1
4
P2
10
P3
6
Appr
51
Most programs:
Boehringer Ingelheim
Boehringer IngelheimCOPD
821 programs253 trialsApproved
Sleep Apnea
144 programs116 trialsApproved
ARDS
4 programs144 trialsPhase 2
Pulmonary Fibrosis
249 programs86 trialsApproved
Obstructive Sleep Apnea
439 programs95 trialsApproved
Interstitial Lung Disease
132 programs88 trialsApproved
Idiopathic Pulmonary Fibrosis
443 programs73 trialsApproved
Rhinitis
48 programs60 trialsApproved
Sinusitis
122 programs66 trialsApproved
Chronic Rhinosinusitis
130 programs53 trialsApproved
Acute Respiratory Distress Syndrome
226 programs53 trialsApproved
Bronchiectasis
218 programs43 trialsApproved
Severe Asthma
53 programs55 trialsPhase 3
Respiratory Failure
211 programs44 trialsApproved
Sarcoidosis
22 programs24 trialsApproved
Eosinophilic Esophagitis
15 programs25 trialsApproved
Chronic Obstructive Pulmonary Disease (COPD)
45 programs32 trialsPhase 3
Bronchopulmonary Dysplasia
211 programs25 trialsApproved
Chronic Rhinosinusitis With Nasal Polyps
111 programs22 trialsApproved
Chronic Cough
11 programs17 trialsApproved
Alpha-1 Antitrypsin Deficiency
316 programs10 trialsPhase 2
Pleural Effusion
39 programs16 trialsApproved
Emphysema
111 programs13 trialsApproved
Idiopathic Pulmonary Fibrosis (IPF)
17 programs16 trialsPhase 3
Acute Respiratory Failure
28 programs14 trialsPhase 3
Acute Respiratory Distress Syndrome (ARDS)
13 programs16 trialsPhase 3
Moderate to Severe Asthma
2 programs16 trialsPhase 2
Showing top 30 diseases by activity. 133 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)